SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017493
Filing Date
2019-11-14
Accepted
2019-11-14 16:26:03
Documents
73
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 992659
2 logo_001.jpg GRAPHIC 136088
3 ex31-1.htm EX-31.1 18021
4 ex32-1.htm EX-32.1 7466
  Complete submission text file 0001493152-19-017493.txt   4078887

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE owpc-20190930.xml EX-101.INS 539584
6 XBRL SCHEMA FILE owpc-20190930.xsd EX-101.SCH 41778
7 XBRL CALCULATION FILE owpc-20190930_cal.xml EX-101.CAL 65859
8 XBRL DEFINITION FILE owpc-20190930_def.xml EX-101.DEF 147828
9 XBRL LABEL FILE owpc-20190930_lab.xml EX-101.LAB 276680
10 XBRL PRESENTATION FILE owpc-20190930_pre.xml EX-101.PRE 251439
Mailing Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118
Business Address 3471 WEST OQUENDO ROAD, SUITE 301 LAS VEGAS NV 89118 7026050605
One World Pharma, Inc. (Filer) CIK: 0001622244 (see all company filings)

IRS No.: 611744826 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-200529 | Film No.: 191220762
SIC: 2834 Pharmaceutical Preparations